A Study of Erdafitinib Versus Investigator Choice of Intravesical Chemotherapy in Participants Who Received Bacillus Calmette-Guérin (BCG) and Recurred With High Risk Non-Muscle-Invasive Bladder Cancer (NMIBC)
Janssen Research & Development, LLC
Janssen Research & Development, LLC
UroGen Pharma Ltd.
Radiation Therapy Oncology Group
UroGen Pharma Ltd.
UroGen Pharma Ltd.
Corewell Health West
Mayo Clinic
UroGen Pharma Ltd.
Viralytics
Halozyme Therapeutics
Bioniche Life Sciences Inc.
Memorial Sloan Kettering Cancer Center